Research & Clinical Studies

Home » Research & Clinical Studies

New Wharton’s Jelly MSC Study: Why Cell Quality Testing Matters

Key Takeaways A 2026 study in Scientific Reports followed 49 patients with steroid-resistant GvHD treated with Wharton’s jelly MSCs at four hospitals in Spain. At day 28, 71.4% of patients responded to treatment. One-year survival reached 55.1%. Batches that scored above 70% on a potency test produced far better outcomes,

June 30, 2026 No Comments

New Stem Cell Research Targets the Root Cause of Type 1 Diabetes

Key Takeaways Researchers at MUSC report that engineered mesenchymal stem cells reversed new-onset type 1 diabetes in mice, pointing to the disease’s immune response rather than just its symptoms. The cells were modified to overexpress a protein called alpha-1 antitrypsin, which calmed the autoimmune attack and protected insulin producing beta

June 16, 2026 No Comments